tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
SWTX is currently covered by 5 analysts with an average price target of $62.85. This is a potential upside of $26.55 (73.14%) from yesterday's end of day stock price of $36.3.
SpringWorks Therapeutics's activity chart (see below) currently has 58 price targets and 66 ratings on display. The stock rating distribution of SWTX is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 49.48% with an average time for these price targets to be met of 137.57 days.
Highest price target for SWTX is $74, Lowest price target is $52, average price target is $62.85.
Most recent stock forecast was given by ROBERT BURNS from HC WAINWRIGHT on 12-Nov-2024. First documented stock forecast 08-Oct-2019.
Currently out of the existing stock ratings of SWTX, 22 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$74
$37.55 (103.02%)
$76
9 days ago
(12-Nov-2024)
3/23 (13.04%)
$40.27 (119.39%)
116
Buy
$63
$26.55 (72.84%)
$47
8 months 23 days ago
(29-Feb-2024)
6/8 (75%)
$13.74 (27.89%)
65
Buy
$70
$33.55 (92.04%)
$50
8 months 26 days ago
(26-Feb-2024)
2/4 (50%)
$21.52 (44.39%)
351
Buy
$52
$15.55 (42.66%)
$49
11 months 23 days ago
(29-Nov-2023)
4/8 (50%)
$25.17 (93.81%)
280
Buy
$58
$21.55 (59.12%)
$57
11 months 30 days ago
(22-Nov-2023)
2/6 (33.33%)
$37.29 (180.06%)
54
What is SWTX (SpringWorks Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on SWTX (SpringWorks Therapeutics) with a proven track record?
Which analyst has the current lower performing score on SWTX (SpringWorks Therapeutics) with a proven track record?
Which analyst has the most public recommendations on SWTX (SpringWorks Therapeutics)?
Which analyst is the currently most bullish on SWTX (SpringWorks Therapeutics)?
Which analyst is the currently most reserved on SWTX (SpringWorks Therapeutics)?
